Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
EJIFCC|December 14, 2019
Immune Cellular Evaluation Following Newborn Screening For Severe T and B Cell LymphopeniaJohannes Wolf, Karolin Dahlenburg, Stephan Borte
International Journal of Clinical Pharmacology and Therapeutics|June 15, 2026
Novel intravenous human IVIG in patients with secondary immunodeficiency: Interim analysis of a multicenter, prospective, non-interventional studyArtur Bauhofer, Silke Aigner, Stephan Borte
Current Opinion in Hematology|October 31, 2012
Guidelines for newborn screening of primary immunodeficiency diseasesStephan Borte, Ulrika von Döbeln, Lennart Hammarström
Vaccines|March 26, 2022
Evaluation of Simple Lateral Flow Immunoassays for Detection of SARS-CoV-2 Neutralizing AntibodiesOlaf Nickel, Alexandra Rockstroh, Stephan Borte, et al.
Iranian Journal of Allergy, Asthma, and Immunology|November 9, 2015
A New IL-2RG Gene Mutation in an X-linked SCID Identified through TREC/KREC Screening: a Case ReportMaryam Nourizadeh, Stephan Borte, Mohammad Reza Fazlollahi, et al.
Annals of the New York Academy of Sciences|January 13, 2012
Newborn screening for primary immunodeficiencies: beyond SCID and XLAStephan Borte, Ning Wang, Sólveig Oskarsdóttir, et al.
Clinical Immunology (Orlando, Fla.)|September 15, 2014
Newborn screening for severe T and B cell lymphopenia identifies a fraction of patients with Wiskott-Aldrich syndromeStephan Borte, Anders Fasth, Ulrika von Döbeln, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 30, 2024
Adequate IVIG dosing is associated with an improved long-term outcome in secondary immunodeficiency: A prospective, non-interventional studyArtur Bauhofer, Ümniye Balaban, Sonja Schimo, et al.
Journal of Clinical Immunology|March 11, 2014
Retrospective analysis of TREC based newborn screening results and clinical phenotypes in infants with the 22q11 deletion syndromeJenny Lingman Framme, Stephan Borte, Ulrika von Döbeln, et al.
Pageof 6